堃博医疗-B（02216.HK）2月5日收盘上涨1.64%，成交41.93万港元

金融界

Feb 05, 2025

2月5日，截至港股收盘，恒生指数下跌0.93%，报20597.09点。堃博医疗-B（02216.HK）收报0.62港元/股，上涨1.64%，成交量68.35万股，成交额41.93万港元，振幅3.28%。

最近一个月来，堃博医疗-B累计涨幅0%，今年来累计涨幅3.39%，跑输恒生指数3.64%的涨幅。

财务数据显示，截至2024年6月30日，堃博医疗-B实现营业总收入2639.77万元，同比减少29.23%；归母净利润-5660.82万元，同比增长46.08%；毛利率79.75%，资产负债率4.11%。

机构评级方面，目前暂无机构对该股做出投资评级建议。

行业估值方面，医疗保健设备和服务行业市盈率（TTM）平均值为2.47倍，行业中值5.28倍。堃博医疗-B市盈率-1.93倍，行业排名第92位；其他巨星医疗控股（02393.HK）为0.12倍、永胜医疗（01612.HK）为3.98倍、环球医疗（02666.HK）为3.99倍、新世纪医疗（01518.HK）为5.14倍、瑞慈医疗（01526.HK）为5.42倍。

资料显示，堃博医疗控股有限公司是介入性肺病学领域的开拓者,在中国和全球范围内提供创新型肺部疾病解决方案。公司利用专有的全肺抵达导航技术,开发了一款包括导航、诊疗的综合介入性肺病学平台,解决了现有诊疗模式的痛点以及巨大未得到满足的肺病医疗需求。

（以上内容为金融界基于公开消息，由程序或算法智能生成，不作为投资建议或交易依据。）

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2509479143"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2509479143\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2509479143?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-02-05 16:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2509479143","market":"hk","top_or_hot":-1,"title":"堃博医疗-B（02216.HK）2月5日收盘上涨1.64%，成交41.93万港元","media":"金融界","content":"<html><body><div>\n<p>2月5日，截至港股收盘，恒生指数下跌0.93%，报20597.09点。<a href=\"https://laohu8.com/S/02216\">堃博医疗-B</a>（02216.HK）收报0.62港元/股，上涨1.64%，成交量68.35万股，成交额41.93万港元，振幅3.28%。</p><p>最近一个月来，堃博医疗-B累计涨幅0%，今年来累计涨幅3.39%，跑输恒生指数3.64%的涨幅。</p><p>财务数据显示，截至2024年6月30日，堃博医疗-B实现营业总收入2639.77万元，同比减少29.23%；归母净利润-5660.82万元，同比增长46.08%；毛利率79.75%，资产负债率4.11%。</p><p>机构评级方面，目前暂无机构对该股做出投资评级建议。</p><p>行业估值方面，医疗保健设备和服务行业市盈率（TTM）平均值为2.47倍，行业中值5.28倍。堃博医疗-B市盈率-1.93倍，行业排名第92位；其他<a href=\"https://laohu8.com/S/02393\">巨星医疗控股</a>（02393.HK）为0.12倍、<a href=\"https://laohu8.com/S/01612\">永胜医疗</a>（01612.HK）为3.98倍、<a href=\"https://laohu8.com/S/02666\">环球医疗</a>（02666.HK）为3.99倍、<a href=\"https://laohu8.com/S/01518\">新世纪医疗</a>（01518.HK）为5.14倍、<a href=\"https://laohu8.com/S/01526\">瑞慈医疗</a>（01526.HK）为5.42倍。</p><p>资料显示，堃博医疗控股有限公司是介入性肺病学领域的开拓者,在中国和全球范围内提供创新型肺部疾病解决方案。公司利用专有的全肺抵达导航技术,开发了一款包括导航、诊疗的综合介入性肺病学平台,解决了现有诊疗模式的痛点以及巨大未得到满足的肺病医疗需求。</p><p>（以上内容为金融界基于公开消息，由程序或算法智能生成，不作为投资建议或交易依据。）</p>\n<div>\n<div>\n</div>\n</div>\n</div></body></html>","source":"jinrongjie_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>堃博医疗-B（02216.HK）2月5日收盘上涨1.64%，成交41.93万港元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n堃博医疗-B（02216.HK）2月5日收盘上涨1.64%，成交41.93万港元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-02-05 16:26 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.jrj.com.cn/2025/02/05162647957846.shtml><strong>金融界</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>2月5日，截至港股收盘，恒生指数下跌0.93%，报20597.09点。堃博医疗-B（02216.HK）收报0.62港元/股，上涨1.64%，成交量68.35万股，成交额41.93万港元，振幅3.28%。最近一个月来，堃博医疗-B累计涨幅0%，今年来累计涨幅3.39%，跑输恒生指数3.64%的涨幅。财务数据显示，截至2024年6月30日，堃博医疗-B实现营业总收入2639.77万元，同比减少...</p>\n\n<a href=\"https://finance.jrj.com.cn/2025/02/05162647957846.shtml\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02216","symbol_name":"堃博医疗-B","start_time":0,"source_url":"https://finance.jrj.com.cn/2025/02/05162647957846.shtml","article_id":"2509479143","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2509479143","pubTimestamp":1738744019,"columns":[],"sourceInfo":{"source_id":"jinrongjie_stock","name":"金融界"},"weMediaInfo":null,"summary":"2月5日，截至港股收盘，恒生指数下跌0.93%，报20597.09点。堃博医疗-B收报0.62港元/股，上涨1.64%，成交量68.35万股，成交额41.93万港元，振幅3.28%。最近一个月来，堃博医疗-B累计涨幅0%，今年来累计涨幅3.39%，跑输恒生指数3.64%的涨幅。财务数据显示，截至2024年6月30日，堃博医疗-B实现营业总收入2639.77万元，同比减少29.23%；归母净利润-5660.82万元，同比增长46.08%；毛利率79.75%，资产负债率4.11%。","collect":0,"end_time":0,"defaultTopTitle":"jrj.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"02216":"堃博医疗-B","BK1100":"医疗保健设备"},"translate_title":"Kunbo Medical-B (02216. HK) closed up 1.64% on February 5, with a turnover of HK $419,300","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02216":1},"content_text":"2月5日，截至港股收盘，恒生指数下跌0.93%，报20597.09点。堃博医疗-B（02216.HK）收报0.62港元/股，上涨1.64%，成交量68.35万股，成交额41.93万港元，振幅3.28%。最近一个月来，堃博医疗-B累计涨幅0%，今年来累计涨幅3.39%，跑输恒生指数3.64%的涨幅。财务数据显示，截至2024年6月30日，堃博医疗-B实现营业总收入2639.77万元，同比减少29.23%；归母净利润-5660.82万元，同比增长46.08%；毛利率79.75%，资产负债率4.11%。机构评级方面，目前暂无机构对该股做出投资评级建议。行业估值方面，医疗保健设备和服务行业市盈率（TTM）平均值为2.47倍，行业中值5.28倍。堃博医疗-B市盈率-1.93倍，行业排名第92位；其他巨星医疗控股（02393.HK）为0.12倍、永胜医疗（01612.HK）为3.98倍、环球医疗（02666.HK）为3.99倍、新世纪医疗（01518.HK）为5.14倍、瑞慈医疗（01526.HK）为5.42倍。资料显示，堃博医疗控股有限公司是介入性肺病学领域的开拓者,在中国和全球范围内提供创新型肺部疾病解决方案。公司利用专有的全肺抵达导航技术,开发了一款包括导航、诊疗的综合介入性肺病学平台,解决了现有诊疗模式的痛点以及巨大未得到满足的肺病医疗需求。（以上内容为金融界基于公开消息，由程序或算法智能生成，不作为投资建议或交易依据。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}